Liu, Y., Fu, X., Wang, Y., Jia, L., Xu, L., Li, R.. Evaluation of influenza vaccine effectiveness among older adults in Jiaxing, China, 2022-2025: A test negative design-based study. Human Vaccines & Immunotherapeutics, 22(1)
Influenza imposes a substantial burden on older adults, underscoring the need for annual evaluation of vaccine effectiveness (VE). Using a test-negative case-control design, this study assessed VE among patients aged ≥60 y with acute respiratory symptoms in Jiaxing, China, across three influenza seasons (2022-2025). Among 3,214 participants, vaccination provided moderate overall protection against laboratory-confirmed influenza, with adjusted VE of 42.5% (95% CI: 31.2-51.9). Protection was highest in the 2024-2025 season (47.2%) and against influenza A(H1N1) (42.4%). Notably, subgroup analyses revealed significantly higher VE among females, individuals without underlying disease (49.2%), those presenting with high fever (>39°C, 44.3%), and within 90 d post-vaccination (52.3%). These findings affirm the moderate protective effect of influenza vaccines in the older individuals and strongly support the critical importance of timely annual vaccination ahead of the influenza season to mitigate risk in this vulnerable population.
See Also:
Latest articles in those days:
- The evolution and transmission dynamics of H3N2 influenza virus identified in a respiratory disease outbreak in companion dogs in Alabama, USA 4 hours ago
- Structural and functional characterization of hemagglutinin E190D and Q226H minor variants in human H5N1 A/British Columbia/PHL-2032/2024 4 hours ago
- Spatial risk factors associated with outbreaks of highly pathogenic avian influenza in Pennsylvania’s commercial poultry farms 4 hours ago
- [preprint]H9N2 avian influenza virus in Bangladesh: three genetically distinct co-circulating subgroups retain a largely conserved antigenic phenotype 4 hours ago
- [preprint]Endogenous serine proteases in MDCK sublines support trypsin-independent influenza A virus replication 4 hours ago
[Go Top] [Close Window]


